Literature DB >> 19004516

Renal structure as an indicator for development of albuminuria in normo- and microalbuminuric type 2 diabetic patients.

Tatsumi Moriya1, Keiji Tanaka, Tatsuki Hosaka, Yoko Hirasawa, Yoshikuni Fujita.   

Abstract

Baseline glomerular structure in microalbuminuric (MA) and proteinuric Caucasian type 2 diabetic patients predicted progressive glomerular filtration rate decline while baseline urinary albumin excretion (UAE) did not. Little is known about whether or not renal structure at the early stages of diabetic nephropathy (DN) in type 2 diabetic patients can predict further functional development of DN. Baseline renal structure and function and follow-up data of renal function were examined in 17 type 2 diabetic patients (11 men, 45+/-7 (mean+/-S.D.) years old) with known diabetes duration 11+/-8 years without definable renal disease other than DN. Six patients showed normoalbuminuria (NA), 11 microalbuminuria (MA), and were followed up for 6.4+/-1.8 years after the baseline renal biopsy. Light and electron microscopic morphometric analyses provided quantitative glomerular and tubulointerstitial structural changes. No statistically significant difference was observed in hemoglobin A1c (HbA1c) values or mean blood pressure (MBP) between baseline and follow-up, even though the number of patients placed on antihypertensive drugs increased from 3 to 7. Follow-up UAE was not significantly different from the baseline UAE although 13 of 17 cases showed an increase. Baseline UAE did not correlate with the follow-up UAE or morphometric measures. Glomerular basement membrane width and volume fraction of the mesangium and mesangial matrix positively correlated with follow-up UAE. In NA and MA Japanese type 2 diabetic patients, baseline renal structural measures are more reliable indicators for the development of UAE than baseline UAE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19004516     DOI: 10.1016/j.diabres.2008.08.015

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study.

Authors:  Tatsumi Moriya; Shiro Tanaka; Ryo Kawasaki; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada; Hirohito Sone; Hidetoshi Yamashita; Shigehiro Katayama
Journal:  Diabetes Care       Date:  2013-04-25       Impact factor: 19.112

2.  Antihypertriglyceridemia and anti-inflammatory activities of monascus-fermented dioscorea in streptozotocin-induced diabetic rats.

Authors:  Yeu-Ching Shi; Jiunn-Wang Liao; Tzu-Ming Pan
Journal:  Exp Diabetes Res       Date:  2011-05-11

3.  Renal histological heterogeneity and functional progress in normoalbuminuric and microalbuminuric Japanese patients with type 2 diabetes.

Authors:  Tatsumi Moriya; Yoshiki Suzuki; Shigeki Inomata; Masayuki Iwano; Masao Kanauchi; Masakazu Haneda
Journal:  BMJ Open Diabetes Res Care       Date:  2014-08-08

4.  Paeoniflorin attenuates incipient diabetic nephropathy in streptozotocin-induced mice by the suppression of the Toll-like receptor-2 signaling pathway.

Authors:  Yun-Xia Shao; Xing-Xin Xu; Kun Wang; Xiang-Ming Qi; Yong-Gui Wu
Journal:  Drug Des Devel Ther       Date:  2017-11-09       Impact factor: 4.162

5.  Paeoniflorin Ameliorates Macrophage Infiltration and Activation by Inhibiting the TLR4 Signaling Pathway in Diabetic Nephropathy.

Authors:  Yun-Xia Shao; Qian Gong; Xiang-Ming Qi; Kun Wang; Yong-Gui Wu
Journal:  Front Pharmacol       Date:  2019-05-22       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.